Evidence map›Paper›PMID 19778901›Full record

ArticleThe Journal of biological chemistry2009

DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.

Li Liu, XiaoJing Shi, Kalyani G Bharadwaj, Shota Ikeda, Haruyo Yamashita, Hiroaki Yagyu, Jean E Schaffer, Yi-Hao Yu, Ira J Goldberg

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Essential Biology of Lipid Droplets.Annual review of biochemistry · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Cardiac Metabolism, Reprogramming, and Diseases.Journal of cardiovascular translational research · 2024
    Review
  15. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  16. Article
  17. Role ofJournal of microbiology and biotechnology · 2023
    Article
  18. The roles of DGAT1 and DGAT2 in human myotubes are dependent on donor patho-physiological background.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  19. Article
  20. Metabolic flux in the driver's seat during cardiac health and disease.Journal of molecular and cellular cardiology · 2023
    Review

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Li LiuDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
XiaoJing ShiDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Kalyani G BharadwajDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Shota IkedaDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Haruyo YamashitaDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Hiroaki YagyuDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Jean E SchafferDivision of Cardiology, Washington University School of Medicine, St. Louis, Missouri 63110.
Yi-Hao YuDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Ira J GoldbergDepartment of Medicine, Division of Preventive Medicine and Metabolism, Columbia University College of Physicians and Surgeons, New York, New York 10032. Electronic address: ijg3@columbia.edu.

Funding

Pathways of Tissue Lipid UptakeR01HL045095 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABUMRAD, NADA A., GOLDBERG, IRA J · 1991 to 2024
$6.9M
Mechanisms of Fatty Acid Uptake By Cardiac MuscleR01HL073029 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GOLDBERG, IRA J · 2003 to 2021
$6.8M
CELLULAR MECHANISMS THAT PROMOTE OR PREVENT LIPOTOXICITYR01DK064989 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2003 to 2021
$5.8M
EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITYR37HL045095 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOLDBERG, IRA J · 2000 to 2009
$4.6M
Cellular mechanisms that promotes or prevent lipotoxicityR56DK064989 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E · 2006 to 2007
$303k
NHLBI NIH HHS HL45095NHLBI NIH HHS HL73029NHLBI NIH HHS R01 HL045095NHLBI NIH HHS R01 HL073029NHLBI NIH HHS R37 HL045095NIDDK NIH HHS DK 064989NIDDK NIH HHS R01 DK064989NIDDK NIH HHS R56 DK064989
6 · The paper itself

Abstract

Intracellular lipid accumulation in the heart is associated with cardiomyopathy, yet the precise role of triglyceride (TG) remains unclear. With exercise, wild type hearts develop physiologic hypertrophy. This was associated with greater TG stores and a marked induction of the TG-synthesizing enzyme diacylglycerol (DAG) acyltransferase 1 (DGAT1). Transgenic overexpression of DGAT1 in the heart using the cardiomyocyte- specific alpha-myosin heavy chain (MHC) promoter led to approximately a doubling of DGAT activity and TG content and reductions of approximately 35% in cardiac ceramide, 26% in DAG, and 20% in free fatty acid levels. Cardiac function assessed by echocardiography and cardiac catheterization was unaffected. These mice were then crossed with animals expressing long-chain acyl-CoA synthetase via the MHC promoter (MHC-ACS), which develop lipotoxic cardiomyopathy. MHC-DGAT1XMHC-ACS double transgenic male mice had improved heart function; fractional shortening increased by 74%, and diastolic function improved compared with MHC-ACS mice. The improvement of heart function correlated with a reduction in cardiac DAG and ceramide and reduced cardiomyocyte apoptosis but increased fatty acid oxidation. In addition, the survival of the mice was improved. Our study indicates that TG is not likely to be a toxic lipid species directly, but rather it is a feature of physiologic hypertrophy and may serve a cytoprotective role in lipid overload states. Moreover, induction of DGAT1 could be beneficial in the setting of excess heart accumulation of toxic lipids.

Indexed as

AnimalsCardiomyopathiesCeramidesDiacylglycerol O-AcyltransferaseDiglyceridesEnzyme InductionFatty Acids, NonesterifiedMaleMiceMice, TransgenicMyocardiumOxidation-ReductionPromoter Regions, GeneticTriglyceridesVentricular MyosinsCeramidesDgat1 protein, mouseDiacylglycerol O-AcyltransferaseDiglyceridesFatty Acids, NonesterifiedTriglyceridesVentricular Myosins

Identifiers

PMID19778901
PMCPMC2794747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.